The FDA approves a new COVID-19 vaccine for children as young as six-months-old

COVID-19 vaccine is stored at -80 degrees celsius in the pharmacy at Roseland Community Hospital on December 18, 2020 in Chicago, Illinois. The hospital began distributing the COVID-19 vaccine to its workers yesterday. (Photo by Scott Olson/Getty Images)COVID-19 vaccine is stored at -80 degrees celsius in the pharmacy at Roseland Community Hospital on December 18, 2020 in Chicago, Illinois. (Photo by Scott Olson/Getty Images)

OAN Newsroom
UPDATED 6:11 PM PT – Thursday, December 8, 2022

The Food and Drug Administration (FDA) has changed their emergency use authorization (EUAs) for COVID vaccines to now include children from five years to six-months-old.

Today, we amended the emergency use authorizations (EUAs) of the updated (bivalent) Moderna and Pfizer-BioNTech COVID-19 vaccines to include use in children down to 6 months of age. https://t.co/dHHwGFJ7fW pic.twitter.com/z4zZNwZZZ0

— U.S. FDA (@US_FDA) December 8, 2022

The agency’s top vaccine regulator Peter Marks announced the emergency use authorization of an updated bivalent COVID-19 vaccine early on Thursday.

This comes after Pfizer and BioNTech sought an authorization from the agency on Monday for the vaccine’s use in children under the age of five.

BREAKING: With our partner @BioNTech_Group, we received EUA from the @US_FDA for our Omicron-adapted #COVID19 vaccine in children 6mos-4yrs. Doses to be shipped immediately upon recommendation by CDC. Learn more: https://t.co/RtTBrUjD0o pic.twitter.com/yhz8QX6j9X

— Pfizer Inc. (@pfizer) December 8, 2022

The FDA currently recommends children to receive three shots of the COVID-19 vaccine. They reportedly expects to receive the data needed to support a fourth dose in January.

CDC data shows only 6.4% percent of children under two have received at least one dose of a COVID vaccine.

Like
Like
Happy
Love
Angry
Wow
Sad
0
0
0
0
0
0

Related Articles